Jeffrey Bland Review: Is Big Bold Health Worth It?

If you've been researching the foundations of functional medicine, Jeffrey Bland's name is unavoidable — and for good reason. He is the person most responsible for creating the field. What is less commonly discussed is that his history includes two documented FTC regulatory actions, a credential critique that has followed him from the earliest days of his career, and a current commercial venture in Big Bold Health that represents a significant pivot from his earlier institutional work. This review covers all of it — credentials, contributions, regulatory history, and what the current offering actually includes.

Who Is Jeffrey Bland?

Jeffrey Bland holds a PhD in biochemistry from the University of Oregon and a BS in biology and chemistry from UC Irvine. He is not a medical doctor — a distinction critics have raised consistently and that is worth knowing clearly. What he is, however, is the person who coined the term "functional medicine" and co-founded the Institute for Functional Medicine with his wife Susan Bland in 1991 — the organization that has since trained hundreds of thousands of healthcare practitioners worldwide and represents the most institutionally credible body in the field.

Before founding IFM, Bland was a tenured professor of biochemistry at the University of Puget Sound, was hand-selected by two-time Nobel Laureate Linus Pauling to serve as Director of Nutritional Research at the Linus Pauling Institute, and was involved in founding Bastyr University — the first federally accredited institution offering degrees in natural medicine in the United States. He has authored more than 120 peer-reviewed research publications and multiple bestselling books, including The Disease Delusion.

His current primary commercial venture is Big Bold Health, founded in 2018, focused on immune rejuvenation through Himalayan Tartary Buckwheat and a related supplement line.

What Does Big Bold Health Include?

Big Bold Health operates as a direct-to-consumer supplement and food product company centered on Himalayan Tartary Buckwheat — a food crop Bland has researched extensively for its polyphenol concentration, including quercetin, rutin, luteolin, hesperidin, and a proprietary compound called 2-HOBA, which Bland identifies as a key driver of immune rejuvenation and cellular protection from oxidative stress.

The product line includes:

• HTB Rejuvenate — the flagship supplement in capsule and superfood powder formats; $82–$95 per 120-capsule bottle

• Microbiome Rejuvenate — a combined probiotic, prebiotic, and gut vitamin formula

• HTB Immune Energy Chews — an on-the-go format with zinc, magnesium, vitamins C and D, and organic HTB

• Energy and Immunity Bundles — combined packages at subscription pricing as low as $1.35–$1.66 per day

Beyond supplements, Bland publishes educational content on immune biology, epigenetics, and longevity, hosts podcast conversations with leading researchers, and maintains an educational presence through the Personalized Lifestyle Medicine Institute — founded in 2012 to extend his systems-biology framework beyond IFM's practitioner training model.

Documented Positive Outcomes

Big Bold Health reviewers describe positive experiences with energy improvement, immune resilience, and reduced inflammatory symptoms — with the HTB Rejuvenate line generating consistent positive feedback from verified purchasers across the company's platform and third-party retailers.

The scientific grounding behind HTB is more substantive than most consumer supplement compounds. Quercetin — the primary polyphenol in Himalayan Tartary Buckwheat — has been studied extensively for its anti-inflammatory, antioxidant, and immunomodulatory properties, with a meaningful published research base. The 2-HOBA compound has been researched in the context of oxidative stress protection and lipid peroxidation inhibition. Bland's institutional credibility — 120+ peer-reviewed publications, the Linus Pauling Institute connection, the IFM founding — means that even critics of his current commercial work engage with a scientific record that is difficult to dismiss.

Practitioners who trained through IFM under Bland's intellectual framework consistently describe the educational contribution as foundational to the entire field.

Complaints and Concerns

The FTC History — The Full Record

This is the most significant documented concern about Jeffrey Bland and it deserves full transparency.

In 1991, the FTC filed a complaint against Nu-Day Enterprises Inc. and its owner Jeffrey Bland, alleging deceptive advertising claims about the Nu-Day Diet Program — specifically, an infomercial claiming the program would alter metabolism such that "extra calories would not lead to extra weight." Bland and Nu-Day settled, agreed to stop the unsubstantiated claims, and paid a $30,000 fine.

In 1995, a second FTC action followed. The Commission obtained a civil penalty of $45,000 from HealthComm, Inc. and Jeffrey Bland for violating the 1992 consent order. The specific allegations: that HealthComm's supplements UltraMaintain and UltraMeal were marketed with claims of mitochondrial alteration, alongside unsubstantiated weight-loss, disease symptom-reduction, toxin-elimination, and cholesterol and blood pressure-reduction claims.

These are settled regulatory actions — not allegations — involving penalties and consent orders. They are part of the permanent public record and they belong in any honest account of his history.

What the record also shows: both cases date to the early 1990s, more than 30 years ago, in a regulatory environment that was in the early stages of establishing FTC standards for health claims. No subsequent FTC action against Bland is documented in available public records. His body of published peer-reviewed research, his IFM institution-building, and the sustained credibility of his contributions across the three decades since represent a substantially different trajectory than those early cases would suggest if read in isolation.

The Credential Critique

Critics in evidence-based medicine circles have specifically cited Bland's PhD in biochemistry — rather than a medical or clinical credential — as a limitation on his authority to develop clinical frameworks. These critiques are documented and sourced, though they tend to conflate Bland's early supplement marketing conduct with his decades-long institutional contribution to functional medicine — a conflation that is analytically imprecise even if the individual critiques have legitimate components.

Big Bold Health Scope

Big Bold Health is a supplement and food company, not a clinical program. For someone carrying complex chronic illness who needs a structured protocol, personalized assessment, and ongoing coaching support, the product line offers nutritional support — but not the phased engagement that root-cause resolution requires.

Cost Breakdown

• HTB Rejuvenate (120 capsules / 60 servings): $82–$95 retail; approximately $1.35/day on subscription

• Microbiome Rejuvenate: Consistent with other supplement products in the line

• Energy and Immunity Bundles: Subscription pricing starting at approximately $1.66/day

• Books: Available via retail at standard pricing

• PLMI and IFM educational programs: Designed for practitioners; pricing varies by program and certification level

Big Bold Health does not offer a consumer health coaching program — it is a supplement and education brand.

Pros and Cons

Pros:

• The most foundational credential in functional medicine — the person who invented the field, built its primary educational institution, and produced 120+ peer-reviewed publications

• HTB polyphenol focus is grounded in real published science — quercetin and related compounds have a substantive research base

• Low cost of entry — supplement line is accessible at a price point far below clinical program costs

• Educational content is among the most research-dense available in the consumer functional health space

• No documented FTC or regulatory action in the 30+ years since the early 1990s settlements

Cons:

• Two documented FTC regulatory actions in the early 1990s involving unsubstantiated supplement and diet marketing claims — settled with penalties and consent orders

• PhD in biochemistry is not a clinical or medical credential — a genuine limitation on clinical authority that critics have consistently raised

• Big Bold Health is a supplement company, not a clinical program — it does not provide the coaching structure, personalized testing, or phased protocol that complex chronic illness requires

• Scope of current offering is narrow relative to Bland's institutional legacy — the gap between what he built and what Big Bold Health delivers is significant